HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paratesticular sarcomas: two cases with different evolutions.

Abstract
Paratesticular sarcomas are rare and account for less than 1% of all adult sarcomas. Intrascrotal tumours can be testicular or paratesticular, paratesticular tumours being rarer (7-10%). Only 30% of paratesticular tumours are malignant and 90% of these are sarcomas. Histological subtypes include leiomyosarcoma, rhabdomyosarcoma, liposarcoma and undifferentiated high-grade pleomorphic sarcoma. Recurrence is frequent in this type of tumour and can occur years from initial diagnosis. These reports show two cases of paratesticular sarcoma with very distinct evolutions. The first case concerns a patient who presented with low-grade leiomyosarcoma with two local recurrences treated with surgery, and distance recurrence with cutaneous, subcutaneous, pulmonary and hepatic metastasis 30 years after surgery of the primary tumour. The second case reports of a patient who presented with high-grade myxoid liposarcoma with local and distance recurrence 3 years after surgery of the primary tumour, which progressed after chemotherapy; the patient died 7 months after diagnosis of recurrence.
AuthorsMargarida Matias, Miguel Carvalho, Luisa Xavier, José Alberto Teixeira
JournalBMJ case reports (BMJ Case Rep) Vol. 2014 (Aug 21 2014) ISSN: 1757-790X [Electronic] England
PMID25145896 (Publication Type: Case Reports, Journal Article)
Copyright2014 BMJ Publishing Group Ltd.
Topics
  • Abdominal Neoplasms (secondary)
  • Abdominal Wall (pathology)
  • Aged
  • Fatal Outcome
  • Humans
  • Leiomyosarcoma (pathology, surgery)
  • Liposarcoma, Myxoid (pathology, surgery)
  • Liver Neoplasms (secondary)
  • Lung Neoplasms (secondary)
  • Male
  • Neoplasm Recurrence, Local (surgery)
  • Skin Neoplasms (secondary)
  • Testicular Neoplasms (pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: